The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 7 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Prasad: Dr. Reddy's clinical trials found no significant medical efficacy in turmeric
“We've done trials with turmeric, we didn't see significant.”
Prasad: Dr. Reddy's found Chinese suppliers more reliable than Indian peers during COVID
“In COVID time, I'm telling you this, in COVID time, we had more reliable supplies from China than from Indian companies.”
Prasad: Pharma companies lack capabilities and struggle to attract top AI talent
“So the AI part is a big deal for us and we are not equipped to do it. Whether it's in our Salesforce management, targeting doctors, all of that can be driven much more efficiently. Through agents and things like that. Our processes, R&D processes can improve. …”
Prasad: Indian pharma now requires extreme competitiveness compared to the 1980s
“When we started our business, you just had to make the product to make money. Now we have to be very good, excellent, highly competitive. The business has become very crowded, there are not many people here, and the whole thing is scaled.”
Prasad: In-licensed Chinese molecule hit ₹100 crore in its launch year
“Not a very huge money. But you know, it's already a hundred crore brand in this year. Launch, year of launch. We could never achieve such results.”
Prasad: Generic injectables avoid human trials by relying on analytical verification
“Injections are simpler in some ways, because you just have to establish analytically that they are the same solution that you are putting in the body. Sometimes they are not, then you have to do studies on humans.”